InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Cawkwell Gail, Directeur Exécutif. Director active across 1 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 11 filings have been logged. The latest transaction was disclosed on 12 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€4,429320 shares@ €13.84084.3% of flow
Common Stock
SEC:0001104659-22-023838:0·
06,600 shares0
Common Stock
SEC:0001104659-22-009553·
06,600 shares0
Common Stock
SEC:0001104659-22-009553:0·
€35,3132,455 shares@ €14.384171.4% of flow
Common Stock
SEC:0001104659-22-000909·
€35,3132,455 shares@ €14.384134.2% of flow
Common Stock
SEC:0001104659-22-000909:0·
€5,304319 shares@ €16.627610.7% of flow
Common Stock
SEC:0001104659-21-140028·
€5,304319 shares@ €16.62765.1% of flow
Common Stock
SEC:0001104659-21-140028:0·
€4,153319 shares@ €13.01958.4% of flow
Common Stock
SEC:0001104659-21-105301·
€4,153319 shares@ €13.01954.0% of flow
Common Stock
SEC:0001104659-21-105301:0·
€4,688319 shares@ €14.69559.5% of flow
Common Stock
SEC:0001104659-21-066143·
€4,688319 shares@ €14.69554.5% of flow
Common Stock
SEC:0001104659-21-066143:0·
11 of 11 declarations
About Cawkwell Gail
Gail Cawkwell is the Executive Vice President of Medical Affairs, Safety & Pharmacovigilance at Intercept Pharmaceuticals, Inc. She is responsible for medical strategy and product safety. Her expertise is essential for ensuring compliance and safety of treatments.
